[Washington, D.C. — March 8, 2025] — Patient safety is the medical device reprocessing industry’s highest priority.  Regulated by the U.S. Food and Drug Administration (FDA), single use device reprocessors are subject to stringent regulation and are required to show that a reprocessed device will remain substantially equivalent to the original device, post-reprocessing. All AMDR

Yesterday Court Issued Final Injunction After Jury Finds that Biosense Webster’s Unlawful, Anti-Competitive Practices Forced Hospitals to Purchase More Costly, Wasteful Products [Washington, D.C. — August 28, 2025] — The Association of Medical Device Reprocessors (AMDR) announced that Judge James Selna of the U.S. District Court for the Central District of California has issued a

Motion filed includes evidence and testimony presented at trial demonstrating the lengths Johnson & Johnson MedTech’s Biosense Webster went to “crush” reprocessor competitors June 20, 2025 FOR IMMEDIATE RELEASE [Note to Editors: The case information discussed in this statement is publicly accessible on PACER and is summarized from the following documents, which AMDR has highlighted